IP Library › Granted Patent US 12,194,280
Granted Patent B2
US 12,194,280 · App. 17/196,744 · Granted Jan 14, 2025

Drug delivery devices and associated heating and/or cooling devices

Inventors: Samin Akbari (Cambridge, MA); Tohid Pirbodaghi (Cambridge, MA); Sheldon B. Moberg (Thousand Oaks, CA)
Assignee: AMGEN INC.
A61M5/24A61M5/32A61M2202/064A61M2205/02A61M2205/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,194,280
App. No.
17/196,744
Granted
Jan 14, 2025
Kind
B2
Abstract

Drug delivery devices and associated heating and/or cooling devices are disclosed. In an example, a drug delivery device includes a housing, a container, a therapy layer, and a first adhesive layer. The housing includes a top wall and a bottom wall. The container is at least partially disposed within the housing. The container has an inner volume to contain a drug. The therapy layer have a first side and a second side. The first side faces the bottom wall and the second side faces away from the bottom wall. The first adhesive layer couples the first side of the therapy layer and the bottom wall. The therapy layer is adapted to at least one of heat or cool an area adjacent an injection site.

Claims (39)

1. A drug delivery device comprising:

a housing including a top wall and a bottom wall;

a container at least partially disposed within the housing, the container having an inner volume to contain a drug;

a therapy layer having a first side and a second side, the first side facing the bottom wall and the second side facing away from the bottom wall; and

a first adhesive layer coupling the first side of the therapy layer and the bottom wall, the first adhesive layer substantially covering the bottom wall and the first side of the therapy layer,

wherein the therapy layer is adapted to at least one of heat or cool an area adjacent to an injection site.

2. The drug delivery device of claim 1 , further comprising a second adhesive layer covering at least a portion of the second side of the therapy layer.

3. The drug delivery device of claim 2 , further comprising a release liner coupled to the second adhesive layer and covering the therapy layer.

4. The drug delivery device of claim 1 , wherein the therapy layer defines a needle access port for allowing a needle and/or cannula to pass through the therapy layer.

5. The drug delivery device of claim 1 , further comprising a drive mechanism at least partially disposed within the housing, the drive mechanism adapted to exert a force to urge the drug out of the container.

6. The drug delivery device of claim 5 , further comprising a needle, a cannula, and an insertion mechanism at least partially disposed within the housing and operably coupled with the drive mechanism, the insertion mechanism adapted to insert the needle and the cannula to deliver the drug.

7. The drug delivery device of claim 1 , wherein the therapy layer comprises:

(a) iron powder, activated carbon, and water,

(b) iron, sodium chloride, and charcoal, or

(c) iron powder, carbon, one or more metal salts, and water.

8. The drug delivery device of claim 7 , wherein the therapy layer comprises (c) and the one or metal salts is selected from (i) the group consisting of alkali metal salts, alkaline earth metal salts, and mixtures thereof, or (ii) the group consisting of sodium chloride, cupric chloride, and mixtures thereof.

9. The drug delivery device of claim 7 , wherein the iron powder is selected from the group consisting of cast iron powder, electrolytic iron powder, scrap iron powder, pig iron, wrought iron, various steels, iron alloys, and mixtures thereof.

10. The drug delivery device of claim 1 , wherein the therapy layer comprises an absorbent material.

11. The drug delivery device of claim 10 , wherein the absorbent material comprises vermiculite.

12. The drug delivery device of claim 1 , wherein the therapy layer comprises a membrane defining an aeration hole.

13. A drug delivery device comprising:

a housing including a top wall and a bottom wall;

a container at least partially disposed within the housing, the container having an inner volume containing a drug;

a therapy layer having a first side including first adhesive coupled to the bottom wall by the first adhesive and a second side including second adhesive; and

a liner covering the second adhesive and the second side of the therapy layer,

wherein the therapy layer is adapted to generate heat or coldness.

14. The drug delivery device of claim 13 , wherein the therapy layer defines a needle access port for allowing a needle and/or cannula to pass through the therapy layer.

15. The drug delivery device of claim 13 , further comprising a needle, a cannula, and an insertion mechanism at least partially disposed within the housing, the insertion mechanism adapted to insert the needle and the cannula to deliver the drug, wherein the therapy layer defines a needle access port and the needle and the cannula are adapted to pass through the needle access port.

16. The drug delivery device of claim 13 , wherein the therapy layer comprises:

(a) iron powder, activated carbon, and water, (b) iron, sodium chloride, and charcoal, or

(c) iron powder, carbon, one or more metal salts, and water.

17. The drug delivery device of claim 16 , wherein the therapy layer comprises (c) and the one or metal salts is selected from (i) the group consisting of alkali metal salts, alkaline earth metal salts, and mixtures thereof, or (ii) the group consisting of sodium chloride, cupric chloride, and mixtures thereof.

18. The drug delivery device of claim 13 , wherein the therapy layer comprises at least one of (a) an absorbent material and (b) a membrane defining an aeration hole.

19. An infusion set comprising:

a needle;

a flexible supply tube;

a hub having a first end and a second end and having a pair of wings extending from sides of the hub, the needle being coupled to the first end of the hub and the flexible supply tube being coupled to the second end of hub; and

a heater coupled to the wings and adapted to generate heat at an injection site during a drug delivery process.

20. The infusion set of claim 19 , wherein the heater comprises a heat therapy adhesive having a removable liner.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: AKBARI, SAMIN; PIRBODAGHI, TOHID; MOBERG, SHELDON B.
To: AMGEN INC.
Reel/Frame 056839/0051 →
Continuity (2)
Provisional Application 63009226 · Apr 13, 2020
Related Publication 20210316075A1 · Oct 14, 2021
References Cited (12)
US 8715232B2 · Yodfat · 2014 [cited by examiner]
US 9333144B2 · Baxter et al. · 2016 [cited by applicant]
US 9808577B2 · Nagar et al. · 2017 [cited by applicant]
US 10149641B2 · O'Malley et al. · 2018 [cited by applicant]
US 10920346B2 · Reneker · 2021 [cited by examiner]
US 20060135911A1 · Mittur · 2006 [cited by applicant]
US 20160045678A1 · Vallero et al. · 2016 [cited by applicant]
US 20170043101A1 · Cole · 2017 [cited by examiner]
US 20170224935A1 · Hoffmann · 2017 [cited by examiner]
US 20200316290A1 · Bourelle · 2020 [cited by examiner]
US 20210353222A1 · Hooven · 2021 [cited by examiner]
WO WO2018170176A1 · 2018 [cited by applicant]